The International Olympic Committee’s decision to require a one-time SRY gene screening for entry into female categories has provoked immediate condemnation from high-profile competitors and experts. In Cape Town on 29 March, former 800m champion Caster Semenya publicly rejected the policy as harmful and demeaning to women, especially those from the global south. The IOC says the measure aims to preserve fairness and safety, particularly in contact sports, by identifying athletes who carry the Y chromosome; opponents say it revives an intrusive and scientifically fraught approach to sex classification.
Supporters of the new rule frame it as a straightforward return to biological criteria for the women’s category, while critics warn of wider consequences for privacy and Human Rights. The plan removes reliance on hormone suppression and shifts eligibility to genetic evidence from a single gene test. This move has prompted immediate activist responses and questions from researchers about the reliability and ethics of reducing sex to the presence or absence of one gene. As the debate intensifies, athletes and governing bodies face the practical task of implementing screening alongside safeguarding concerns.
What the rule requires and how the IOC justifies it
Under the new protocol, athletes who want to compete in events listed as female at Olympic competitions must submit to a one-time genetic sex test that checks for the SRY gene on the Y chromosome. If the gene is detected, the athlete will be classified as not biologically female for eligibility purposes. The IOC frames this as a science-based policy intended to protect fairness and integrity in sports that depend on strength, power and endurance. Although the committee has cited performance differentials to support the change, it has not published the specific studies underpinning its conclusions, leaving some observers demanding more transparency about the evidence base.
Historical precedents and scientific debate
Chromosomal or genetic screening is not new to elite sport: versions of sex verification were used between 1968 and 1996 before being abandoned amid concerns about false positives and the complexity of human biology. Critics now point to those earlier problems as a warning, arguing that the presence of a single gene does not neatly translate into competitive advantage for all individuals. Scientists such as Professor Alun Williams have highlighted ethical pitfalls in mass genetic testing, especially for young athletes, and cautioned against oversimplifying sex variation into binary categories for the purpose of exclusion.
Exemptions and disputed advantages
The IOC’s framework reportedly includes an exemption for athletes with complete androgen insensitivity syndrome (CAIS), who do not undergo typical male puberty, but it otherwise treats detectable male sex development as disqualifying. The committee has asserted that male physiology confers measurable performance benefits in many disciplines, citing percentage figures for various events. Those numbers have fuelled debate: some medical experts accept a general male advantage at elite levels, while others warn that the magnitude and universality of those gains remain contested and sport-specific.
Voices from the track and the broader fallout
Responses from athletes have been stark. Caster Semenya said the policy felt like an affront to women and stressed the disproportionate harm it could cause to athletes from Africa and other parts of the global south. US runner Nikki Hiltz, who identifies as transgender and non-binary and has medalled at major championships, used social media to condemn the measure as part of a pattern where attacks on trans people expand surveillance over all women’s bodies. Hiltz also argued that extremely few openly trans women have competed at recent Olympics, questioning the premise that this policy solves a real problem facing women’s sport.
Practical and ethical implications
Beyond headline reactions, the new testing regime raises logistical and moral questions: how to manage consent and confidentiality, how to support athletes who test positive, and how to handle minors who might be subjected to genetic screening. The IOC has encouraged federations to provide mental health and safeguarding resources and to respect privacy, but implementing robust protections while carrying out broad testing will be challenging. Critics worry about the return of intrusive scrutiny, potential misclassification, and the reintroduction of stigma attached to natural biological diversity.
As sports bodies, lawyers and medical professionals unpack the ruling, governing federations will need to decide whether to mirror the IOC’s approach or craft sport-specific rules — a split that could produce a patchwork of eligibility standards across disciplines. With prominent athletes publicly opposing the move and scientists urging caution, the controversy is unlikely to fade. The conversation now centers on whether genetic screening can be administered fairly and humanely, or whether it will deepen divisions and undermine the inclusivity and dignity of those who compete in women’s sport.